David Hallett

David Hallett

Chief Tech/Sci/R&D Officer at RECURSION PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 2026-05-30

56 year
Consumer Services
Health Technology
Commercial Services

Profile

David Hallett is Chief Scientific Officer at Recursion Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Hallett was CEO, Executive Director & Chief Science Officer at Exscientia Ltd. in 2024 and EVP-Chemistry & Alliance Management at Evotec (UK) Ltd. from 2005 to 2019.
Education includes a doctorate from The University of Manchester and an undergraduate degree from the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-14 1,070,494 ( 0.2% ) 4 M $ 2026-05-30

David Hallett active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2024-11-19

Former positions of David Hallett

CompaniesPositionEnd
EXSCIENTIA PLC Chief Executive Officer 2024-11-19
Corporate Officer/Principal 2019-11-30
See the detail of David Hallett's experience

Training of David Hallett

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Commercial Services

Technology Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!